MIGNAR MF 25MG TABLET
GLENMARK PHARMACEUTICAL LTD
MIGNAR MF 25MG TABLET belongs to the class of medications called ‘antidiabetic drugs’ used to treat type 2 diabetes mellitus. Type 2 diabetes mellitus is a chronic or life-long condition in which blood sugar or glucose levels rise more than normal. It occurs when the body does not produce enough insulin (utilises glucose to produce energy) or if produced, it cannot function properly in the body.
MIGNAR MF 25MG TABLET contains Miglitol and Metformin. Metformin acts by decreasing liver glucose production and intestinal glucose uptake. Miglitol works by inhibiting intestinal enzymes that break complex sugars into simple sugars like glucose. Together, MIGNAR MF 25MG TABLET can effectively prevent the rise in glucose levels in the body.
You should take this medicine exactly as prescribed by the doctor. The common side-effects of MIGNAR MF 25MG TABLET are flatulence (gas), diarrhoea, abdominal pain, feeling sick (nausea), being sick (vomiting) and loss of appetite. These side-effects can be reduced if this medicine is taken with food or after a meal. However, if any of these side-effects persist or get worse, inform your doctor immediately.
It is not recommended to take MIGNAR MF 25MG TABLET if you are allergic to any contents of it. MIGNAR MF 25MG TABLET is not recommended if you are having any intestinal problems such as inflammation, ulcers, blockage, hernia, liver problems, severe kidney impairment, uncontrolled diabetes, severe dehydration, severe infections, and a recent history of heart attack or heart failure. MIGNAR MF 25MG TABLET is not recommended for children and adolescents below 18 years, pregnant women, and breastfeeding mothers. It should be used with caution in elderly people as they may require dose adjustments. MIGNAR MF 25MG TABLET may interact with alcohol and worsen the condition. MIGNAR MF 25MG TABLET may cause hypoglycemia (low glucose levels), so avoid driving if you develop weakness, dizziness, fast heartbeat or decrease in alertness.
Type 2 diabetes mellitus
Store in a cool and dry place away from sunlight
MIGNAR MF 25MG TABLET may cause a rare and serious side-effect ‘lactic acidosis’ (buildup of lactic acid in the blood), characterized by abdominal pain, muscle cramps, vomiting, severe fatigue, and difficulty breathing. It is a life-threatening condition that requires immediate medical attention. Inform your doctor if you have any severe liver or kidney problems as their normal functioning is required to eliminate excess lactic acid from the body. Consumption of alcohol, prolonged fasting, dehydration, uncontrolled diabetes, serious infections, and liver problems increases the risk of lactic acidosis. If you have dehydration (severe loss of body fluids) due to severe vomiting, diarrhoea, exposure to heat, or fever, stop taking MIGNAR MF 25MG TABLET and immediately seek medical attention. MIGNAR MF 25MG TABLET may cause hypoglycemia (low blood sugar) and its symptoms include sweating, dizziness, palpitations (pounding heartbeat), and shivering, etc. Whenever you experience any of these symptoms, immediately consume candies or glucose biscuits rather than ordinary sugar. If your condition doesn’t improve, consult your doctor immediately.
Consumption of alcohol may increase the risk of side-effects and worsen the condition.
MIGNAR MF 25MG TABLET is a category B medicine and may not cause harmful effects to the unborn baby. However, it should be used in pregnant women only if clinically needed.
MIGNAR MF 25MG TABLET should not be given to breastfeeding mothers as it may pass in breast milk and cause adverse effects in the nursing baby.
MIGNAR MF 25MG TABLET may impair alertness or decrease concentration, so avoid driving or operating heavy machinery in such cases.
MIGNAR MF 25MG TABLET should be used with caution in patients with liver diseases. The dose may have to be adjusted by your doctor.
MIGNAR MF 25MG TABLET is not recommended for use in patients with severe kidney impairment. In patients with mild to moderate kidney diseases, your doctor may have to adjust the dose.
This item is Not Returnable.
Expires on or after - September 2021
MIGNAR MF 25MG TABLET is used in the treatment of type 2 diabetes mellitus. It contains Miglitol and Metformin. Metformin acts by decreasing liver glucose production and intestinal glucose uptake. Miglitol works by inhibiting intestinal enzymes that break complex sugars into simple sugars like glucose. Together, MIGNAR MF 25MG TABLET can effectively prevent the rise in glucose levels in the body.
MIGNAR MF 25MG TABLET can be taken on an empty stomach. However, it is advised to take with food or after meals to reduce the bowel side-effects and increase its efficiency.
Inform your doctor before having an X-ray or CT scan that you are taking MIGNAR MF 25MG TABLET. Some imaging scans may involve the use of the injection of contrast materials that contain iodine. Concomitant use of this injection with MIGNAR MF 25MG TABLET may affect your kidney function. So, the doctor may advise you to stop MIGNAR MF 25MG TABLET before the examination and will decide when to restart it.
MIGNAR MF 25MG TABLET may cause hypoglycemia (low blood sugar level) characterized by sweating, dizziness, palpitations, shivering, confusion, irritability, etc. If you experience these symptoms, try to eat candies or glucose biscuits. If your condition doesn't improve, consult your doctor immediately.
MIGNAR MF 25MG TABLET is recommended for the treatment of type 2 diabetes and not used for treating type 1 diabetes, a condition which occurs mainly due to deficiency of insulin.
Glenmark Pharmaceuticals Limited, B/2, Mahalaxmi Chambers, 22, Bhulabhai Desai Road, Mumbai – 400 026.
10 Tablet in 1 Strip